News & Updates

The development of nonalcoholic fatty liver disease (NAFLD) and progression of fibrosis contribute to a higher risk of incident chronic kidney disease (CKD), suggests a recent study.

Treatment with corticosteroids (CS) among children with multisystem inflammatory syndrome (MIS-C) cardiovascular involvement temporarily associated with COVID-19 leads to faster normalization of left ventricular ejection fraction (LVEF), fever, improved laboratory analysis, and shorter intensive care unit stay than treatment with intravenous immunoglobulin (IVIG), a study has shown.

Both exogenous hyper- and hypothyroidism may increase the risk of incident stroke, according to a study, which notes the importance of patient medication safety.

Maintenance treatment with bimekizumab achieves complete scalp, palmoplantar, or nail clearance in patients with moderate-to-severe plaque psoriasis, according to two phase III trials presented at EADV 2021.

The oral selective Janus kinase 1/2 inhibitor baricitinib, when added to standard of care (SoC), reduced the risk of mortality among adults hospitalized with COVID-19. However, the primary outcome of disease progression was not met in the baricitinib group, results of the phase III COV-BARRIER study showed.

Negative upper endoscopy findings in patients with gastroesophageal reflux disease (GERD) indicate lower risk of developing upper gastrointestinal cancer, a new study has found.